-
Adobe Inc. ($ADBE) Is Poised To Rally Soon From a Blue Box Area.
Read MoreHello Traders! Today, we will look at the Daily Elliott Wave structure of Adobe Inc. ($ADBE) and explain why the stock should soon reach a Blue Box area and react higher. Adobe Inc. is an American multinational computer software company incorporated in Delaware and headquartered in San Jose, California. It has historically specialized in software for the creation and publication of a […]
-
$BKNG: Buying Booking Holdings Stock in a Pullback
Read MoreBooking Holdings Inc. is an US American travel technology company. It owns and operates several travel fare aggregators and travel fare metasearch engines including namesake and flagship Booking.com
-
Silver Miners (SIL) Still Finding Bottom
Read MoreThe silver miners ETF (SIL) is an exchange-traded fund that seeks to track the performance of companies primarily engaged in silver mining. By investing in SIL, investors gain exposure to a diversified portfolio of silver mining companies, offering potential benefits of capital appreciation and portfolio diversification within the precious metals sector. In this article, we […]
-
AbbVie Inc. ($ABBV) Bullish Structure Calling for More Upside Since July 2023.
Read MoreHello Traders. In today’s article, we are going to follow up on AbbVie Inc. ($ABBV) forecast that was posted back in July 2023 and take a look at the latest count. You can find the article here. $ABBV Daily Elliott Wave View July 2023: Our remarks from July 2023 were as follows: “The Daily chart above shows the […]
-
BlackRock (NYSE: BLK) New Bullish Sequence To the Upside
Read MoreBlackRock (NYSE: BLK) is the world’s largest asset manager, with $9.42 trillion in assets as of June 30, 2023. Headquartered in New York City, Blackrock has 70 offices in 30 countries, and clients in 100 countries. In this article, we will be taking a look at the technical structure for the stock based on the Elliott Wave Theory and we’ll […]
-
$GILD: Gilead Sciences Stock Approaches Daily Buying Area
Read MoreGilead Sciences, Inc. is an US American biopharmaceutical company. It focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir and sofosbuvir. In the 2000s, Gilead received approval for drugs including Viread and Hepsera, among others. It began evolving from a biotechnology company into a pharmaceutical company, acquiring several subsidiaries, though it still relied heavily on contracting to […]